Writer
Katherashala Dharan Kumar
PharmD
Katherashala Dharan Kumar, PharmD A dedicated Clinical Researcher with expertise in medical and scientific writing clinical trials, drug safety, and healthcare innovation. Actively contributes to research publications and clinical documentation focused on improving patient outcomes through evidence-based practices and ethical research standards. Believe that every complex data point has a human story waiting to be told. Focusing on providing actionable insights for clinical research
18
Articles written or reviewed
About Katherashala
Katherashala Dharan Kumar (PharmD) is a writer at Pharmacally, with 18 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Katherashala Dharan Kumar
Health TidingsCapricor’s Deramiocel BLA Review Reinstated by FDA Following HOPE-3 Trial Data
Clinical TrialsRoche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY Trial Published in NEJM
Health TidingsGSK Finalizes $2.2B RAPT Buyout: Ozureprubart Eyes Quarterly Dosing for Food Allergies
Health TidingsJohnson & Johnson Advances Nipocalimab in Lupus with Latest FDA Fast Track Nod
Clinical TrialsAbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’s Disease: Phase 3 AFFIRM Data
Health TidingsEarendil Labs Secures $885M WuXiTecan-2 Rights from WuXi XDC
Health TidingsFDA Grants Priority Review to Garetosmab for Rare Bone Disorder FOP
Health TidingsJanux Therapeutics Dosed First Patient in JANX011 StudyOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala